FDA Inspection 992915 — Guangxi Yulin Pharmaceutical Group Co. Ltd.
The FDA completed an inspection of Guangxi Yulin Pharmaceutical Group Co. Ltd. on September 29, 2016 in Yulin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 29, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yulin (China)